We are live on ! Find out more
TECH icon

Bio-Techne

248 hedge funds and large institutions have $3.38B invested in Bio-Techne in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 88 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

5% more funds holding

Funds holding: 237248 (+11)

2% more capital invested

Capital invested by funds: $3.32B → $3.38B (+$57.8M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 88

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $187K

Holders
248
Holders Change
+11
Holders Change %
+4.64%
% of All Funds
7.2%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
29
Increased
87
Reduced
88
Closed
16
Calls
Puts
$187K
Net Calls
-$187K
Net Calls Change
-$187K
Name Holding Trade Value Shares
Change
Change in
Stake
DRZID
26
DePrince Race & Zollo Inc (DRZ)
Florida
$43.3M -$1.48M -63,280 -3%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$40.3M +$1.26M +53,588 +3%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$38.8M +$1.74M +74,304 +5%
DDC
29
DF Dent & Co
Maryland
$33.4M +$22.6M +965,488 +208%
WA
30
Wasatch Advisors
Utah
$32M -$3.88M -165,508 -11%
Norges Bank
31
Norges Bank
Norway
$30.8M -$27.8M -1,186,216 -47%
ACM
32
Atlanta Capital Management
Georgia
$27.1M -$472K -20,132 -2%
Citadel Advisors
33
Citadel Advisors
Florida
$21.1M -$7.09M -302,404 -25%
Schroder Investment Management Group
34
Schroder Investment Management Group
United Kingdom
$19.9M
Ameriprise
35
Ameriprise
Minnesota
$19.9M +$390K +16,640 +2%
GCM
36
Geneva Capital Management
Wisconsin
$19.1M -$432K -18,448 -2%
Fidelity International
37
Fidelity International
Bermuda
$18.8M -$1.18M -50,480 -6%
RFC
38
Russell Frank Company
Washington
$18.3M -$416K -17,744 -2%
MSA
39
Mason Street Advisors
Wisconsin
$17.9M +$2.21M +94,176 +14%
Wells Fargo
40
Wells Fargo
California
$17.6M -$1.97M -84,000 -10%
BTW
41
Boston Trust Walden
Massachusetts
$17.4M -$767K -32,732 -4%
Geode Capital Management
42
Geode Capital Management
Massachusetts
$16.7M +$161K +6,868 +1%
CCA
43
Conestoga Capital Advisors
Pennsylvania
$16.2M +$92.3K +3,940 +0.6%
MAA
44
Managed Account Advisors
New Jersey
$14.4M -$500K -21,348 -3%
SIMG
45
Stephens Investment Management Group
Texas
$14.2M -$15K -640 -0.1%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$12.1M -$5.59M -238,700 -32%
Goldman Sachs
47
Goldman Sachs
New York
$12M -$1.21M -51,440 -9%
TCIM
48
TIAA CREF Investment Management
New York
$11.6M +$178K +7,576 +2%
NFA
49
Nationwide Fund Advisors
Ohio
$10.7M -$62.7K -2,676 -0.6%
Deutsche Bank
50
Deutsche Bank
Germany
$10.2M +$588K +25,092 +6%

TECH Hedge Fund Activity: Q3 2014 in Review

248 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2014, worth a combined $3.38B — up 1.7% from $3.32B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TECH positions and 16 closed out — a net gain of 13 holders — while 87 added to existing stakes and 88 trimmed.

The largest buyer was Invesco, adding an estimated $33.3M. The largest seller was Norges Bank, cutting an estimated $27.8M.

  • 248 institutional investors held Bio-Techne (TECH) as of Q3 2014, up from 237 in Q2 2014.
  • Funds reported $3.38B of Bio-Techne stock for Q3 2014, up 1.7% quarter-over-quarter.
  • 29 funds opened new Bio-Techne positions in Q3 2014 and 16 closed out, a net change of +13 holders.
  • The largest Bio-Techne buyer in Q3 2014 was Invesco, an estimated $33.3M added.
  • The largest Bio-Techne seller in Q3 2014 was Norges Bank, an estimated $27.8M sold.

Based on aggregated 13F filings for Q3 2014.